Your browser doesn't support javascript.
loading
Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.
Chari, Ajai; Suvannasankha, Attaya; Fay, Joseph W; Arnulf, Bertrand; Kaufman, Jonathan L; Ifthikharuddin, Jainulabdeen J; Weiss, Brendan M; Krishnan, Amrita; Lentzsch, Suzanne; Comenzo, Raymond; Wang, Jianping; Nottage, Kerri; Chiu, Christopher; Khokhar, Nushmia Z; Ahmadi, Tahamtan; Lonial, Sagar.
Afiliação
  • Chari A; Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY.
  • Suvannasankha A; Indiana University School of Medicine and Simon Cancer Center, Richard L. Roudebush VA Medical Center, Indianapolis, IN.
  • Fay JW; Baylor Institute for Immunology Research, Dallas, TX.
  • Arnulf B; Unité d'Immuno-hématologie, Assistance Publique-Hôpitaux de Paris, Centre d'Investigations Cliniques 1427, Hôpital Saint Louis Lariboisière, Paris, France.
  • Kaufman JL; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.
  • Ifthikharuddin JJ; James P. Wilmot Cancer Center, University of Rochester Strong Memorial Hospital, Rochester, NY.
  • Weiss BM; Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Krishnan A; The Judy and Bernard Briskin Myeloma Center, City of Hope, Duarte, CA.
  • Lentzsch S; Columbia University Medical Center, New York, NY.
  • Comenzo R; Division of Hematology-Oncology, Tufts Medical Center, Boston, MA.
  • Wang J; Janssen Research & Development, Raritan, NJ; and.
  • Nottage K; Janssen Research & Development, Raritan, NJ; and.
  • Chiu C; Janssen Research & Development, Spring House, PA.
  • Khokhar NZ; Janssen Research & Development, Spring House, PA.
  • Ahmadi T; Janssen Research & Development, Spring House, PA.
  • Lonial S; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.
Blood ; 130(8): 974-981, 2017 08 24.
Article em En | MEDLINE | ID: mdl-28637662

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talidomida / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais / Mieloma Múltiplo / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talidomida / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais / Mieloma Múltiplo / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2017 Tipo de documento: Article